BONVIVA IV drug use results surveillance

BONVIVA IV drug use results surveillance - BONVIVA IV drug use results surveillance

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013413

Enrollment

Registered

2014-03-17

Start date

2014-03-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have no previous treatment with BONVIVA for osteoporosis and are diagnosed with osteoporosis and Grade 4 or 5 chronic kidney disease (CKD) (eGFR<30mL/min, including renal replacement therapy)

Exclusion criteria

Exclusion criteria: No criteria

Design outcomes

Primary

Measure	Time frame
Adverse reaction incidence	—

Countries

Japan

Contacts

Public ContactAyaka Shimizu

Chugai Pharmaceutical Co. Ltd. Real World Data Science Dept.

shimizuayk@chugai-pharm.co.jp03-3273-0905

Outcome results